Literature DB >> 10631139

Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.

M P Sperandeo1, M T Bassi, M Riboni, G Parenti, A Buoninconti, M Manzoni, B Incerti, M R Larocca, M Di Rocco, P Strisciuglio, I Dianzani, R Parini, M Candito, F Endo, A Ballabio, G Andria, G Sebastio, G Borsani.   

Abstract

Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of cationic amino acid transport caused by mutations in the SLC7A7 gene. We report the genomic structure of the gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. The SLC7A7 gene consists of 10 exons; sequences of all of the exon-intron boundaries are reported here. All of the mutant alleles were characterized and eight novel mutations were detected, including two missense mutations, 242A-->C (M1L) and 1399C-->A (S386R); a nonsense mutation 967G-->A (W242X); two splice mutations IVS3 +1G-->A and IVS6 +1G-->T; a single-base insertion, 786insT; and two 4-bp deletions, 455delCTCT and 1425delTTCT. In addition, a previously reported mutation, 1625insATCA, was found in one patient. It is noteworthy that 242A-->C causes the change of Met1 to Leu, a rare mutational event previously found in a few inherited conditions. We failed to establish a genotype/phenotype correlation. In fact, both intrafamilial and interfamilial phenotypic variability were observed in homozygotes for the same mutation. The DNA-based tests are now easily accessible for molecular diagnosis, genetic counseling, and prenatal diagnosis of LPI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631139      PMCID: PMC1288352          DOI: 10.1086/302700

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

Review 1.  The structure and insertion of integral proteins in membranes.

Authors:  S J Singer
Journal:  Annu Rev Cell Biol       Date:  1990

2.  A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency.

Authors:  R Parini; M Vegni; M Pontiggia; D Melotti; C Corbetta; A Rossi; L Piceni Sereni
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells.

Authors:  M Kozak
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

4.  Multiple mutations in a specific gene in a small geographic area: a common phenomenon?

Authors:  J Zlotogora; V Gieselmann; G Bach
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

5.  Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.

Authors:  M Candito; C Vianey-Saban; J P Ferraci; B Bébin; J P Chazalette; F Sebag; M Mathieu; P Chambon
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Role of haematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance.

Authors:  M DiRocco; G Garibotto; G A Rossi; U Caruso; A Taccone; P Picco; C Borrone
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

7.  The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Authors:  G Sebastio; M P Sperandeo; M Panico; R de Franchis; J P Kraus; G Andria
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

8.  Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report.

Authors:  M P Sperandeo; A Buoninconti; A Passariello; I Scala; A Adami; T Lauteala; J Mykkänen; G Andria; G Sebastio
Journal:  Prenat Diagn       Date:  1999-08       Impact factor: 3.050

9.  SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family.

Authors:  M T Bassi; M P Sperandeo; B Incerti; A Bulfone; A Pepe; E M Surace; C Gattuso; A De Grandi; A Buoninconti; M Riboni; M Manzoni; G Andria; A Ballabio; G Borsani; G Sebastio
Journal:  Genomics       Date:  1999-12-01       Impact factor: 5.736

Review 10.  Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course.

Authors:  G Parenti; G Sebastio; P Strisciuglio; B Incerti; C Pecoraro; L Terracciano; G Andria
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

View more
  15 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  First report of a molecular prenatal diagnosis in a tunisian family with lysinuric protein intolerance.

Authors:  Nadia Esseghir; Chiraz Souissi Bouchlaka; Sondess Hadj Fredj; Amel Ben Chehida; Hatem Azzouz; Monique Fontaine; Neji Tebib; Marie Françoise Ben Dridi; Gilbert Briand; Taieb Messaoud; Amel Ben Ammar Elgaaied; Naziha Kaabachi
Journal:  JIMD Rep       Date:  2011-06-22

3.  Growth hormone deficiency in a patient with lysinuric protein intolerance.

Authors:  Valentina Esposito; Teresa Lettiero; Simona Fecarotta; Gianfranco Sebastio; Giancarlo Parenti; Mariacarolina Salerno
Journal:  Eur J Pediatr       Date:  2006-06-15       Impact factor: 3.183

4.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

5.  Genetic Basis of Children's Interstitial Lung Disease.

Authors:  Lawrence M Nogee
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

6.  Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance.

Authors:  Y Kamada; H Nagaretani; S Tamura; T Ohama; T Maruyama; H Hiraoka; S Yamashita; A Yamada; S Kiso; Y Inui; N Ito; Y Kayanoki; S Kawata; Y Matsuzawa
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 7.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

8.  First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Authors:  Loreta Cimbalistiene; Willy Lehnert; Kirsi Huoponen; Vaidutis Kucinskas
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

9.  Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.

Authors:  Mariona Font-Llitjós; Benjamín Rodríguez-Santiago; Meritxell Espino; Ruth Sillué; Sandra Mañas; Laia Gómez; Luis A Pérez-Jurado; Manuel Palacín; Virginia Nunes
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

10.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.